Big Fat Unilever and the Diet Heart Hypothesis

This unadulterated episode of 8RD+ Versustakes features the Dutch-based EUR 53.3 billion revenue conglomerate Unilever in the world of FATTY ACIDS. As a theoretical framework we are probing the subjects of asymmetric information, impression management, planned obsolescence, and of course my favorite term FRAGILITY. In laymen terms, we are talking about who controls the markets […]

Rock Steady but Fragile: Will Biohacking Sting Big Pharma to Death?

This time is different – this is a start that the reader might think Carmen Reinhart and Kenneth Rogoff could begin with – and yes, this time the reader really faces a new writer instead of the Ultra High-Frequency Trading oriented academic behind the pen name 7/.V. In due arithmetic progression, let’s call me 8RD+, […]

2 AUTHORS VERSUS 1 STAKE

Alternative investments covered alternatively. By two pen names.

antifragile

Big Fat Unilever and the Diet Heart Hypothesis

Rock Steady but Fragile: Will Biohacking Sting Big Pharma to Death?